Ongoing Clinical Trial Studying the Efficacy of Pembrolizumab in Non-Small Cell Lung Cancer
Lung Cancer
A Phase II clinical trial supervised by Joshua Bauml of Penn’s Abramson Cancer Center will assess whether Pembrolizumab, a drug already in use for melanoma treatment, can improve survival in ... Read more